World's Best Scientists 2026 revealed!
Tanios Bekaii-Saab

Tanios Bekaii-Saab

D-Index & Metrics

Biology and Biochemistry

D-Index
74
Citations
22367
World Ranking
5537
National Ranking
2631

Tanios Bekaii-Saab publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Tanios Bekaii-Saab sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 601 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Tanios Bekaii-Saab D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Tanios Bekaii-Saab sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 74 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Tanios Bekaii-Saab is affiliated with the Mayo Clinic in the United States and has a focused research portfolio in medicine, particularly in oncology. Their work encompasses various subfields including oncology, pulmonary and respiratory medicine, surgery, cancer research, and pathology and forensic medicine.

The scientist's research covers a range of main topics, such as:

  • Colorectal Cancer Treatments and Studies
  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Gastric Cancer Management and Outcomes
  • Cancer Immunotherapy and Biomarkers
  • Genetic factors in colorectal cancer

Some of their most cited recent papers include:

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, 2020, The Lancet
  • Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C, 2022, New England Journal of Medicine
  • Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study, 2021, The Lancet. Gastroenterology & Hepatology
  • NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial, 2023, The Lancet
  • Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium, 2021, Annals of Oncology

The scientist frequently collaborates with a group of coauthors, including:

  • Daniel H. Ahn
  • Mohamad Bassam Sonbol
  • Mitesh J. Borad
  • John H. Strickler
  • Pedro Luiz Serrano Usón

Their work is published predominantly in journals such as:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • ONCOLOGY
  • The Oncologist
  • European Journal of Cancer

Best Publications

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

    Nicole M. Kuderer;Toni K. Choueiri;Dimpy P. Shah;Yu Shyr

  • Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

    Andrea Wang-Gillam;Chung-Pin Li;György Bodoky;Andrew Dean

  • Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

    Milind Javle;Maeve Lowery;Rachna T. Shroff;Karl Heinz Weiss

  • Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.

    Matthew H.G. Katz;Qian Shi;Syed A. Ahmad;Joseph M. Herman

  • IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

    Thomas A Mace;Reena Shakya;Jason R Pitarresi;Benjamin Swanson

  • Pain, depression, and fatigue: loneliness as a longitudinal risk factor.

    Lisa M. Jaremka;Rebecca R. Andridge;Christopher P. Fagundes;Catherine M. Alfano

  • Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner

    Thomas A Mace;Zeenath Ameen;Amy Collins;Sylwia E. Wojcik

  • Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.

    Rachna T. Shroff;Erin B. Kennedy;Melinda Bachini;Tanios Bekaii-Saab

  • Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.

    Van K. Morris;Mohamed E. Salem;Halla Nimeiri;Syma Iqbal

  • Biliary cancer: Utility of next-generation sequencing for clinical management.

    Milind Javle;Tanios Bekaii-Saab;Apurva Jain;Ying Wang

  • Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial

    Rachna T. Shroff;Milind M. Javle;Lianchun Xiao;Ahmed O. Kaseb

  • Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers

    Tanios Bekaii-Saab;Mitch A. Phelps;Xiaobai Li;Motoyasu Saji

  • Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.

    Milind Javle;Sameek Roychowdhury;Robin Kate Kelley;Saeed Sadeghi

  • Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

    P. Grivas;A. R. Khaki;A. R. Khaki;T. M. Wise-Draper;B. French

  • Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines

    Al B. Benson;Alan P. Venook;Tanios Bekaii-Saab;Emily Chan

  • Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas

    Marlo Blazer;Christina Wu;Richard M. Goldberg;Gary Phillips

  • Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis

    Quisette P. Janssen;Stefan Buettner;Mustafa Suker;Berend R. Beumer

  • Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study.

    Tanios S. Bekaii-Saab;Fang Shu Ou;Daniel H. Ahn;Patrick M. Boland

  • Colon Cancer, Version 3.2014

    Al B. Benson;Alan P. Venook;Tanios Bekaii-Saab;Emily Chan

  • Gastric cancer: Clinical practice guidelines in oncology™

    Jaffer A. Ajani;James S. Barthel;Tanios Bekaii-Saab;David J. Bentrem

Frequent Co-Authors

Richard M. Goldberg
Richard M. Goldberg West Virginia University
Axel Grothey
Axel Grothey University of Tennessee at Knoxville
Ching-Shih Chen
Ching-Shih Chen The Ohio State University
Alan P. Venook
Alan P. Venook University of California, San Francisco
Michael R. Grever
Michael R. Grever The Ohio State University
William E. Carson
William E. Carson The Ohio State University
Gregory A. Otterson
Gregory A. Otterson The Ohio State University
Robin Kate Kelley
Robin Kate Kelley University of California, San Francisco
Denis C. Guttridge
Denis C. Guttridge Medical University of South Carolina

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Biology or Biochemistry opens the door to a wide range of related online degrees. Many students pursue advanced healthcare leadership roles, and you can do so flexibly with dnp program no clinical requirements if you’re interested in nursing leadership without extensive clinical hours.

Those drawn to health services administration can consider doctoral programs for healthcare administration. These programs emphasize strategic management skills for healthcare settings, making them a top choice for future hospital and clinic leaders.

Pharmacy is a common next step for Biochemistry graduates, and flexible online pharm d programs let you work towards becoming a licensed pharmacist from anywhere, often while fulfilling professional obligations.

If you’re interested in human physiology, wellness, or sports science, consider an online exercise science degree. Careers in this field range from athletic training to rehabilitation and fitness management. Each of these online degrees can complement a background in Biology or Biochemistry and help expand your career options in the healthcare and science sectors.

Best Scientists Citing Tanios Bekaii-Saab

Trending Scientists

Recently Published Articles